Reports
Sale
Europe Intracranial Aneurysm Market Size, Share, Trends: By Treatment Type: Endovascular Coiling, Surgical Clipping, Flow Diverters, Other Treatment Types; By End Use: Hospitals, Clinics, Other End-Users; Regional Analysis; Market Dynamics: SWOT Analysis, Porter’s Five Forces Analysis, Others; Supplier Landscape; 2024-2032
Europe Intracranial Aneurysm Market Outlook
The global intracranial aneurysm market size was valued at USD 1.2 billion in 2023, with Europe holding a significant market share. The market is driven by the growing demand for minimally invasive procedures. It is expected to grow at a CAGR of 8.8% during the forecast period of 2024-2032, with the values likely to attain USD 2.6 billion by 2032.
Key Takeaways
- Ruptured intracranial aneurysms are considered fatal in around 50% of cases, with recent data suggesting that about 25% of people die within the first 24 hours of the rupture and nearly 50% die within 3 months. The growing demand for effective treatment alternatives is expected to bolster market growth.
- One of the major Europe intracranial aneurysm market trends is the increased strategic growth initiatives by the key market players to boost their presence in the European market. In January 2024, Evasc Neurovascular announced expansion plans for its neurovascular treatment portfolio in the European market through the establishment of a German subsidiary, Evasc Neurovascular GmbH.
- Increased access to novel devices in the region is expected to lead to higher adoption rates in the healthcare sector and fuel market demand. Nautilus intrasaccular system, developed by Endostream Medical was indicated as the “next evolution” in aneurysm care at the European Society of Minimally Invasive Neurological Therapy (ESMINT), conducted in September 2023, the. The intrasaccular flow diverter, intended for the treatment of intracranial aneurysms, is CE-marked and is available in the European market.
Europe Intracranial Aneurysm Market Analysis
Intracranial aneurysm or brain aneurysm usually occurs at the underside of the brain and the base of the skull and is characterized by ballooning or bulging in a blood vessel in the brain. The condition can affect anyone at any age, but they are more common in people aged 40 or older. Additionally, women are more susceptible to develop the condition as compared to men. The rising advancements in treatment options and diagnostic techniques are resulting in increased treatment-seeking behavior and early diagnosis rates, which is expected to drive Europe intracranial aneurysm market growth in the coming years.
When an intracranial aneurysm ruptures, bleeding occurs in the tissue surrounding the brain. The condition is fatal in around 50% of cases of ruptured brain aneurysms. Recent data suggests that about 25% of people die within the first 24 hours of the rupture and nearly 50% die within 3 months. This indicates the immediate need for effective treatment alternatives that can tackle the rising cases of mortality associated with ruptured aneurysms in the brain. Further, increased investment in the development of innovative diagnostic techniques is expected to lead to early diagnosis and improve patient outcomes. Consequently, this is poised to fuel Europe intracranial aneurysm market demand in the forecast period.
Europe has a large patient pool affected by intracranial aneurysms owing to the increasing geriatric population more prone to the condition. The rising prevalence of the disease makes Europe a lucrative market, attracting investments from the leading market players. For example, in January 2024, Evasc Neurovascular, a medical device company specializing in endovascular repair of cerebral aneurysms, announced strategic growth initiatives that involved the expansion plans of its neurovascular treatment portfolio in the European market through the establishment of a German subsidiary, Evasc Neurovascular GmbH. The company which recently boasted 120 successful intracranial aneurysm cases with its novel Eclips device is expected to advance neurovascular care in the region. Thus, the strong presence of key market players not only improves access to treatment options but also significantly contributes to augmenting Europe intracranial aneurysm market value.
The market is witnessing a steady development and commercialization of innovative endovascular techniques and devices, leading to higher adoption rates of these safer and more effective alternatives. In September 2023, the Nautilus intrasaccular system developed by Endostream Medical (a company developing solutions for brain aneurysms) was indicated as the “next evolution” in aneurysm care at the European Society of Minimally Invasive Neurological Therapy (ESMINT). The intrasaccular flow diverter, intended for the treatment of intracranial aneurysms, is CE-marked and is available in the European market. The increased accessibility to such novel devices is expected to result in faster recovery times and reduced morbidity and mortality rates, thereby propelling market growth in the region.
Europe Intracranial Aneurysm Market Segmentation
The report a detailed analysis of the market based on the following segments:
| Market Breakup | Categories |
| Treatment Type | Endovascular Coiling, Surgical Clipping, Flow Diverters, Other Treatment Types |
| End User | Hospitals, Clinics, Others |
| Countries | United Kingdom, Germany, France, Italy, Others |
Europe Intracranial Aneurysm Market: Competitor Landscape
The key features of the market report include patent analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Medtronic
- Stryker
- MicroPort Scientific Corporation
- Johnson & Johnson Services, Inc
- MicroVention Inc
- Integra LifeSciences
- B. Braun Melsungen AG
- Delta Surgical
- Mizuho Medical Co. Ltd.
- Penumbra, Inc
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Treatment Type |
|
| Breakup by End Use |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Europe Intracranial Aneurysm Market Overview
3.1 Europe Intracranial Aneurysm Market Historical Value (2017-2023)
3.2 Europe Intracranial Aneurysm Market Forecast Value (2024-2032)
4 Europe Intracranial Aneurysm Market Landscape*
4.1 Europe Intracranial Aneurysm Market: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Europe Intracranial Aneurysm Market: Product Landscape
4.2.1 Analysis by Product
4.2.2 Analysis by Material
4.2.3 Analysis by Type
5 Europe Intracranial Aneurysm Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter’s Five Forces Analysis
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Europe Intracranial Aneurysm Market Segmentation (2017-2032)
6.1 Europe Intracranial Aneurysm Market (2017-2032) by Treatment Type
6.1.1 Market Overview
6.1.2 Endovascular Coiling
6.1.3 Surgical Clipping
6.1.4 Flow Diverters
6.1.5 Other Treatment Types
6.2 Europe Intracranial Aneurysm Market (2017-2032) by End Use
6.2.1 Market Overview
6.2.2 Hospitals
6.2.3 Clinics
6.2.4 Other End-Users
6.3 Europe Intracranial Aneurysm Market (2017-2032) by Countries
6.3.1 Market Overview
6.3.2 United Kingdom
6.3.3 Germany
6.3.4 France
6.3.5 Italy
6.3.6 Others
7 United Kingdom Intracranial Aneurysm Market (2017-2032)
7.1 United Kingdom Intracranial Aneurysm Market (2017-2032) By Treatment Type
7.1.1 Market Overview
7.1.2 Endovascular Coiling
7.1.3 Surgical Clipping
7.1.4 Flow Diverters
7.1.5 Other Treatment Types
7.2 United Kingdom Intracranial Aneurysm Market (2017-2032) by End Use
7.2.1 Market Overview
7.2.2 Hospitals
7.2.3 Clinics
7.2.4 Other end-users
8 Germany Intracranial Aneurysm Market (2017-2032)
8.1 Germany Intracranial Aneurysm Market (2017-2032) by Treatment Type
8.1.1 Market Overview
8.1.2 Endovascular Coiling
8.1.3 Surgical Clipping
8.1.4 Flow Diverters
8.1.5 Other Treatment Types
8.2 Germany Intracranial Aneurysm Market (2017-2032) by End Use
8.2.1 Market Overview
8.2.2 Hospitals
8.2.3 Clinics
8.2.4 Other end-users
9 France Intracranial Aneurysm Market (2017-2032)
9.1 France Intracranial Aneurysm Market (2017-2032) by Treatment Type
9.1.1 Market Overview
9.1.2 Endovascular Coiling
9.1.3 Surgical Clipping
9.1.4 Flow Diverters
9.1.5 Other Treatment Types
9.2 France Intracranial Aneurysm Market (2017-2032) by End Use
9.2.1 Market Overview
9.2.2 Hospitals
9.2.3 Clinics
9.2.4 Other end-users
10 Italy Intracranial Aneurysm Market (2017-2032)
10.1 Italy Intracranial Aneurysm Market (2017-2032) by Treatment Type
10.1.1 Market Overview
10.1.2 Endovascular Coiling
10.1.3 Surgical Clipping
10.1.4 Flow Diverters
10.1.5 Other treatment types
10.2 Italy Intracranial Aneurysm Market (2017-2032) by End Use
10.2.1 Market Overview
10.2.2 Hospitals
10.2.3 Clinics
10.2.4 Other end-users
11 Regulatory Framework
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Funding and Investment Analysis
13.1 Analysis by Funding Instances
13.2 Analysis by Type of Funding
13.3 Analysis by Funding Amount
13.4 Analysis by Leading Players
13.5 Analysis by Leading Investors
13.6 Analysis by Geography
14 Partnership and Collaborations Analysis
14.1 Analysis by Partnership Instances
14.2 Analysis by Type of Partnership
14.3 Analysis by Leading Players
14.4 Analysis by Geography
15 Supplier Landscape
15.1 Market Share by Top 5 Companies
15.2 Medtronic
15.2.1 Financial Analysis
15.2.2 Product Portfolio
15.2.3 Demographic Reach and Achievements
15.2.4 Mergers and Acquisitions
15.2.5 Certifications
15.3 Stryker
15.3.1 Financial Analysis
15.3.2 Product Portfolio
15.3.3 Demographic Reach and Achievements
15.3.4 Mergers and Acquisitions
15.3.5 Certifications
15.4 MicroPort Scientific Corporation
15.4.1 Financial Analysis
15.4.2 Product Portfolio
15.4.3 Demographic Reach and Achievements
15.4.4 Mergers and Acquisitions
15.4.5 Certifications
15.5 Johnson & Johnson Services, Inc
15.5.1 Financial Analysis
15.5.2 Product Portfolio
15.5.3 Demographic Reach and Achievements
15.5.4 Mergers and Acquisitions
15.5.5 Certifications
15.6 MicroVention Inc
15.6.1 Financial Analysis
15.6.2 Product Portfolio
15.6.3 Demographic Reach and Achievements
15.6.4 Mergers and Acquisitions
15.6.5 Certifications
15.7 Integra LifeSciences
15.7.1 Financial Analysis
15.7.2 Product Portfolio
15.7.3 Demographic Reach and Achievements
15.7.4 Mergers and Acquisitions
15.7.5 Certifications
15.8 B. Braun Melsungen AG
15.8.1 Financial Analysis
15.8.2 Product Portfolio
15.8.3 Demographic Reach and Achievements
15.8.4 Mergers and Acquisitions
15.8.5 Certifications
15.9 Delta Surgical
15.9.1 Financial Analysis
15.9.2 Product Portfolio
15.9.3 Demographic Reach and Achievements
15.9.4 Mergers and Acquisitions
15.9.5 Certifications
15.10 Mizuho Medical Co. Ltd.
15.10.1 Financial Analysis
15.10.2 Product Portfolio
15.10.3 Demographic Reach and Achievements
15.10.4 Mergers and Acquisitions
15.10.5 Certifications
15.11 Penumbra, Inc
15.11.1 Financial Analysis
15.11.2 Product Portfolio
15.11.3 Demographic Reach and Achievements
15.11.4 Mergers and Acquisitions
15.11.5 Certifications
16 Europe Intracranial Aneurysm Market – Distribution Model (Additional Insight)
16.1 Overview
16.2 Potential Distributors
16.3 Key Parameters for Distribution Partner Assessment
17 Key Opinion Leaders (KOL) Insights (Additional Insight)
18 Company Competitiveness Analysis (Additional Insight)
18.1 Very Small Companies
18.2 Small Companies
18.3 Mid-Sized Companies
18.4 Large Companies
18.5 Very Large Companies
19 Payment Methods (Additional Insight)
19.1 Government Funded
19.2 Private Insurance
19.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
Key Questions Answered in the Report
The Europe intracranial aneurysm market is expected to be driven by the rising demand in the global market, which is anticipated to grow at a CAGR of 8.8% during the forecast period of 2024-2032 and is likely to reach a market value of USD 2.6 billion by 2032.
The growing demand for minimally invasive procedures and the rising healthcare expenditure are fuelling the demand for the market.
One of the significant trends in the market is the increased strategic growth initiatives by the key market players to boost their presence in the European market. In January 2024 , Evasc Neurovascular announced its expansion plans for its neurovascular treatment portfolio in the European market through the establishment of a German subsidiary, Evasc Neurovascular GmbH.
Based on the treatment type, the market is segmented into endovascular coiling, surgical clipping, and flow diverters, among other treatment types.
End users of the market are hospitals and clinics, among other end-users.
The market segmentation by countries includes the United Kingdom, Germany, France, and Italy, among others.
The key players in the market are Medtronic, Stryker, MicroPort Scientific Corporation, Johnson & Johnson Services, Inc., MicroVention Inc., Integra LifeSciences, B. Braun Melsungen AG, Delta Surgical, Mizuho Medical Co. Ltd., and Penumbra, Inc.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2639
$2399
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 4399
$3999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 5829
$5299
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 6929
$6299
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER